Evidence map›Paper›PMID 39425597›Full record

ArticleActa ophthalmologica2025

Grading of diabetic retinopathy using a pre-segmenting deep learning classification model: Validation of an automated algorithm.

Dyllan Edson Similié, Jakob K H Andersen, Sebastian Dinesen, Thiusius R Savarimuthu, Jakob Grauslund

Abstract readValidation Study
In one paragraph

Article in Acta ophthalmologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dyllan Edson SimiliéDepartment of Ophthalmology, Odense University Hospital, Odense, Denmark.
Jakob K H AndersenThe Maersk Mc-Kinney Moeller Institute, SDU Robotics, University of Southern Denmark, Odense, Denmark.ORCID https://orcid.org/0000-0003-3238-868X
Sebastian DinesenDepartment of Ophthalmology, Odense University Hospital, Odense, Denmark.
Thiusius R SavarimuthuThe Maersk Mc-Kinney Moeller Institute, SDU Robotics, University of Southern Denmark, Odense, Denmark.
Jakob GrauslundDepartment of Ophthalmology, Odense University Hospital, Odense, Denmark.ORCID https://orcid.org/0000-0001-5019-0736

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo validate the performance of autonomous diabetic retinopathy (DR) grading by comparing a human grader and a self-developed deep-learning (DL) algorithm with gold-standard evaluation.

methodsWe included 500, 6-field retinal images graded by an expert ophthalmologist (gold standard) according to the International Clinical Diabetic Retinopathy Disease Severity Scale as represented with DR levels 0-4 (97, 100, 100, 103, 100, respectively). Weighted kappa was calculated to measure the DR classification agreement for (1) a certified human grader without, and (2) with assistance from a DL algorithm and (3) the DL operating autonomously. Using any DR (level 0 vs. 1-4) as a cutoff, we calculated sensitivity, specificity, as well as positive and negative predictive values (PPV and NPV). Finally, we assessed lesion discrepancies between Model 3 and the gold standard.

resultsAs compared to the gold standard, weighted kappa for Models 1-3 was 0.88, 0.89 and 0.72, sensitivities were 95%, 94% and 78% and specificities were 82%, 84% and 81%. Extrapolating to a real-world DR prevalence of 23.8%, the PPV were 63%, 64% and 57% and the NPV were 98%, 98% and 92%. Discrepancies between the gold standard and Model 3 were mainly incorrect detection of artefacts (n = 49), missed microaneurysms (n = 26) and inconsistencies between the segmentation and classification (n = 51).

conclusionWhile the autonomous DL algorithm for DR classification only performed on par with a human grader for some measures in a high-risk population, extrapolations to a real-world population demonstrated an excellent 92% NPV, which could make it clinically feasible to use autonomously to identify non-DR patients.

Indexed as

AlgorithmsDeep LearningDiabetic RetinopathyRetinaAgedFemaleHumansMaleMiddle AgedReproducibility of ResultsRetrospective StudiesSeverity of Illness Indexautomated classificationdecision supportdeep‐learningdiabetic retinopathyvalidation

Identifiers

PMID39425597
PMCPMC11810534

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.